Feasibility of low dose interleukin-2 therapy following T cell-depleted non-myeloablative allogeneic hematopoietic stem cell transplantation from HLA matched or mismatched family member donors

High relapse rates and infections remain primary causes of failure in non-myeloablative transplantation. Interleukin-2 (IL-2) may stimulate the immune system and improve outcomes. The primary objective of this pilot study was to evaluate the feasibility of administering IL-2 following a T cell-deple...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Rizzieri, David A., Crout, Christopher, Storms, Robert, Golob, Jared, Long, Gwynn D., Gasparetto, Cristina, Sullivan, Keith M., Horwitz, Mitchell, Chute, John, Lagoo, Anand S., Morris, Ashley, Beaven, Anne, Yang, Yiping, Peterson, Bercedis, Li, Zhiguo, Chao, Nelson J.
Format: Artigo
Język:Inglês
Wydane: 2011
Hasła przedmiotowe:
Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3619422/
https://ncbi.nlm.nih.gov/pubmed/21166499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/07357907.2010.535055
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy